PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-64

  1. 564 Posts.
    lightbulb Created with Sketch. 182
    wow everyone got doom and gloom.

    relax, the day isn't over...

    more than likely shorters exiting. There is just as much interest on the buyer side propping things up in light of the aggressive selling.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.